Proton therapy reduces bowel and bladder radiation dose versus photons in prostate cancer WPRT
Can proton therapy reduce radiation exposure to healthy organs in prostate cancer?
A multicenter randomized trial comparing proton- versus photon-based whole-pelvic radiotherapy in 5 patients with high-risk prostate cancer …
Proton therapy consistently lowers radiation doses to the bowel and bladder during prostate cancer treatment while matching standard methods…
Psychoeducational interventions improve sexual function and satisfaction in prostate cancer patients
Study finds counseling and exercise programs may help prostate cancer patients with sexual health
A meta-analysis of 14 studies found psychoeducational and physical activity-based interventions significantly improved sexual function (SMD=…
Counseling and exercise programs help prostate cancer patients improve sexual function and satisfaction, according to a review of 14 studies…
Systematic review of 18 case reports characterizes apalutamide-induced severe cutaneous adverse reactions in prostate cancer
Study reviews rare but severe skin reactions to prostate cancer drug apalutamide
A systematic review of 18 global case reports in prostate cancer patients found apalutamide was associated with severe cutaneous adverse rea…
Severe skin reactions like Stevens-Johnson syndrome appeared in most cases of patients taking apalutamide for prostate cancer, starting abou…
CDSS Dashboard Implementation Associated with Higher CRPC Detection in Prostate Cancer Cohort
Can a digital dashboard help doctors spot prostate cancer progression sooner?
A retrospective single-centre cohort study of prostate cancer patients on ADT found that implementing a Clinical Decision Support System das…
A digital dashboard helped doctors spot prostate cancer progression sooner and catch unstable warning signs in patients already on hormone t…
Prostate cancer death rates decreased among US males from 1999 to 2017
Prostate cancer deaths dropped by nearly half in the US over two decades.
An observational analysis of US vital statistics from 1999 to 2017 found the age-adjusted prostate cancer death rate among males decreased f…
Prostate cancer deaths in the US dropped nearly half between 1999 and 2017, with the death rate falling from 31.3 to 18.7 per 100,000 men.
Synchronous bone-metastatic prostate cancer incidence 6% with median survival of 43 months in Chinese cohort
What happens when prostate cancer spreads to bones at diagnosis?
A retrospective cohort study of patients with synchronous bone-metastatic hormone-sensitive prostate cancer at a Chinese tertiary center fou…
About 6% of men diagnosed with prostate cancer already have it spread to their bones, where high-volume disease doubles the risk of death.
Feasibility study fails to meet recruitment target for HDR brachytherapy vs SBRT in recurrent prostate cancer
Why is it so hard to recruit men for a second prostate cancer radiation study?
A 3-center randomized feasibility study of 23 patients with locally recurrent prostate cancer found planned recruitment targets were not met…
Men refused to let chance decide their second prostate cancer radiation treatment, causing a major study to fall far short of its recruitmen…
PSMA PET parameters predict biochemical recurrence in high-risk prostate cancer after neoadjuvant hormonal therapy
PET scan measures may help predict prostate cancer recurrence after hormone therapy
A phase II RCT of 89 high-risk primary prostate cancer patients found that posttreatment PSMA-expressing volume and pretreatment metastatic …
A specialized PET scan after hormone therapy can predict which high-risk prostate cancer patients face a higher risk of their disease return…
Metabolomics meta-analysis finds metabolites associated with prostate cancer risk, including lethal disease
Could a simple blood test one day predict aggressive prostate cancer?
A systematic review and meta-analysis of 12 observational studies examined associations between pre-diagnostic circulating metabolites and p…
A blood test could one day predict lethal prostate cancer, with 19 specific molecules linked to risk and 13 potentially modifiable by diet o…
Ga-PSMA-11 PET/CT staging predicts outcomes in unfavorable intermediate- and high-risk prostate cancer
Can a new scan predict prostate cancer outcomes before surgery?
A prospective multicenter trial of 775 patients with newly diagnosed unfavorable intermediate- or high-risk prostate cancer found Ga-PSMA-11…
A new prostate scan predicts survival chances, showing men with distant spread face only 26 percent two-year survival without cancer returni…
Online rehabilitation program for sexual minority prostate cancer patients shows acceptability but minimal functional improvement
Can an online program help gay men recover sexual function after prostate cancer?
A randomized controlled trial of 401 US sexual minority men with prostate cancer tested an online biopsychobehavioral rehabilitation program…
An online rehab program for gay men after prostate cancer was easy to use but failed to improve sexual or urinary function compared to stand…